Shrividya Iyer

Shrividya (Shri) Iyer is a Principal part of our Value, Pricing & Access practice area. Shri has 20+ years’ experience in the pharmaceutical industry building and leading global health economics outcomes research (HEOR)/ RWE teams across diverse therapeutic areas. In her most recent role Shri was Executive Director, Oncology Worldwide Real World Evidence and US HEOR with Eisai, Inc. Shri has expertise and extensive experience in developing and executing a comprehensive HEOR strategy including clinical, patient reported, economic outcomes and RWE related to pipeline, launch and marketed products meeting the needs of diverse health care stakeholders worldwide including regulators, HTAs, payers/policymakers, HCPs and clinical pathway developers.  Shri has published extensively in leading peer reviewed scientific journals with reputed KOLs/investigators and presented at clinical and HEOR conferences worldwide. Shri has a PhD in pharmaceutical socioeconomics from the University of Iowa, USA, a degree in pharmacy from University of Mumbai, India and a Certificate in Business Excellence in Digital Health from the Columbia Business School, New York.